20142242

Source:http://linkedlifedata.com/resource/pubmed/id/20142242

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0033105, umls-concept:C0039286, umls-concept:C0041703, umls-concept:C0043210, umls-concept:C0278925
pubmed:issue	2
pubmed:dateCreated	2010-2-9
pubmed:abstractText	Tamoxifen can reduce the risk of developing invasive estrogen receptor-positive breast cancer by 49%, but it is unknown how many women in the United States are taking tamoxifen for primary prevention of breast cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/Z99 CA999999
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-10547390, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-11508619, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-12559863, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-12671020, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-15213495, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-15825209, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-15916987, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-15928228, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-16108294, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-16754727, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-17327893, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-17385998, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-17942271, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-18300064, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-18602242, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-18755566, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-19221371, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-19290712, http://linkedlifedata.com/resource/pubmed/commentcorrection/20142242-9747868
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9200608
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Selective Estrogen Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1538-7755
pubmed:author	pubmed-author:CroninKathleen AKA, pubmed-author:FreedmanAndrew NAN, pubmed-author:GraubardBarry IBI, pubmed-author:HanPaul KPK, pubmed-author:WatersErika AEA
pubmed:issnType	Electronic
pubmed:volume	19
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	443-6
pubmed:dateRevised	2011-9-29
pubmed:meshHeading	pubmed-meshheading:20142242-Adult, pubmed-meshheading:20142242-Aged, pubmed-meshheading:20142242-Breast Neoplasms, pubmed-meshheading:20142242-Female, pubmed-meshheading:20142242-Humans, pubmed-meshheading:20142242-Middle Aged, pubmed-meshheading:20142242-Prevalence, pubmed-meshheading:20142242-Primary Prevention, pubmed-meshheading:20142242-Selective Estrogen Receptor Modulators, pubmed-meshheading:20142242-Tamoxifen, pubmed-meshheading:20142242-United States
pubmed:year	2010
pubmed:articleTitle	Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.
pubmed:affiliation	Cancer Prevention Fellowship Program, Center for Cancer Training, Health Communication and Informatics Research Branch/Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA. waterse@wudosis.wustl.edu
pubmed:publicationType	Journal Article, Research Support, N.I.H., Extramural